Clinical and Translational Oncology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Aim and Scope

Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists.

About Clinical and Translational Oncology

Clinical and Translational Oncology is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Oncology (Q2); Cancer Research (Q3). It is published by Springer-Verlag Italia s.r.l.. The overall rank of Clinical and Translational Oncology is 5667. According to SCImago Journal Rank (SJR), this journal is ranked 0.903. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 65. The best quartile for this journal is Q2.

The ISSN of Clinical and Translational Oncology journal is 1699048X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical and Translational Oncology is cited by a total of 2363 articles during the last 3 years (Preceding 2024).

Clinical and Translational Oncology Impact IF 2024-2025

The Impact IF 2024 of Clinical and Translational Oncology is 2.96, which is computed in 2025 as per its definition. Clinical and Translational Oncology IF is decreased by a factor of 0.08 and approximate percentage change is -2.63% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Clinical and Translational Oncology Impact IF 2025 Prediction

Impact IF 2024 of Clinical and Translational Oncology is 2.96. If the same downward trend persists, Impact IF may fall in 2025 as well.

Clinical and Translational Oncology h-index

 

Clinical and Translational Oncology has an h-index of 65. It means 65 articles of this journal have more than 65 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Clinical and Translational Oncology ISSN

The ISSN of Clinical and Translational Oncology is 1699048X. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Clinical and Translational Oncology Rank and SCImago Journal Rank (SJR)

The overall rank of Clinical and Translational Oncology is 5667. According to SCImago Journal Rank (SJR), this journal is ranked 0.903. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Clinical and Translational Oncology by Year

Ranking of Clinical and Translational Oncology by Year

Clinical and Translational Oncology Publisher

Clinical and Translational Oncology is published by Springer-Verlag Italia s.r.l.. It's publishing house is located in Italy. Coverage history of this journal is as following: 2000-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

Call For Papers

Visit the official website of the journal/conference to check the further details about the call for papers.

Abbreviation

The IS0 4 standard abbreviation of Clinical and Translational Oncology is Clin. Transl. Oncol.. This abbreviation ('Clin. Transl. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.

How to publish in Clinical and Translational Oncology

If your research field is/are related to Medicine (miscellaneous) (Q2); Oncology (Q2); Cancer Research (Q3), then please visit the official website of this journal.

Acceptance Rate

The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

• The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
• Peer review complexity and timeline.
• The mix of unsolicited and invited submissions.
• The time it takes from manuscript submission to final publication.
• And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/